STIMATE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
When do Stimate patents expire, and when can generic versions of Stimate launch?
Stimate is a drug marketed by Ferring Pharms Inc and is included in one NDA.
The generic ingredient in STIMATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stimate
A generic version of STIMATE was approved as desmopressin acetate by TEVA PHARMS USA on October 15th, 1997.
Summary for STIMATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 25 |
| Clinical Trials: | 4 |
| Patent Applications: | 716 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for STIMATE |
| What excipients (inactive ingredients) are in STIMATE? | STIMATE excipients list |
| DailyMed Link: | STIMATE at DailyMed |
Recent Clinical Trials for STIMATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Genentech, Inc. | Phase 4 |
| Indiana Hemophilia &Thrombosis Center, Inc. | Phase 4 |
| Canadian Hemophilia Society | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for STIMATE
US Patents and Regulatory Information for STIMATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | STIMATE | desmopressin acetate | SPRAY, METERED;NASAL | 020355-001 | Mar 7, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ferring Pharms Inc | STIMATE (NEEDS NO REFRIGERATION) | desmopressin acetate | SPRAY, METERED;NASAL | 020355-002 | Oct 24, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
